Biosimilars are biologic medicines that are similar to an already approved original biologic medicine, known as the reference medicine or reference product. Biosimilars are developed to be similar to their reference product, but there may be minor differences between the reference product and biosimilar in clinically inactive components. Biosimilars can provide increased treatment opt... https://www.newsanalyticspro.com/cancer-treatment/